|
"hsu chih hung"的相關文件
顯示項目 151-174 / 174 (共4頁)
<< < 1 2 3 4
每頁顯示[10|25|50]項目
| 國立臺灣大學 |
2005 |
Combined Modality Therapy (Transurethral Surgery, Induction Chemotherapy, Followed by Concurrent Chemoradiotherapy) for Bladder Preservation for Patients with Muscle Invasive Bladder Cancer: Preliminary Report
|
徐志宏; 林家齊; 成佳憲; 鄭安理; 黃昭淵; 陳淳; 蒲永孝; HSU, CHIH-HUNG; LIN, CHIA-CHI; CHENG, JASON CHIA-HSIEN; CHENG, ANN-LII; HUANG, CHAO-YUAN; CHEN, JUN; PU, YEONG-SHIAU |
| 國立臺灣大學 |
2005 |
A Phase Ii Study Using Multi-Fractionation of Paclitaxel and Cisplatin by Twice Weekly Schedule, Plus Weekly 24-Hour Infusion of High-Dose 5- Fluorouacil and Leucovorin (Twice Weekly Tp-Hdfl) in the Treatment of Metastatic or Recurrent Esophageal Cancer: T
|
林家齊; 徐志宏; 葉坤輝; 許駿; 蔡育傑; 鄭安理; LIN, CHIA-CHI; HSU, CHIH-HUNG; YEH, KUN-HUEI; HSU, CHIUN; TSAI, YU-CHIEH; CHENG, ANN-LII |
| 國立臺灣大學 |
2005 |
Inhibitors of Epidermoid Growth Factor Receptor Suppress Cell Growth and Enhance Chemosensitivity of Nasopharyngeal Cancer Cells in Vitro
|
徐志宏; 高明; 陳志榮; 葉培彥; 鄭安理; HSU, CHIH-HUNG; GAO, MING; CHEN, CHI-LONG; YEH, PEI-YEN; CHENG, ANN-LII |
| 國立臺灣大學 |
2005 |
Survival Outcome of Inoperable Non-Small Cell Lung Cancer Patients Receiving Conventional Dose Epirubicin and Paclitaxel as First-Line Treatment
|
楊志新; 陳明君; 鄭安理; 徐志宏; 葉坤輝; 汪彭嘉康; 楊泮池; YANG, CHIH-HSIN; CHEN, MIN-CHUN; CHENG, ANN-LII; HSU, CHIH-HUNG; YEH, KUN-HUEI; JACQUELINE, WHANG-PENG; YANG, PAN-CHYR |
| 國立臺灣大學 |
2005 |
Phase Ii Study of Weekly Paclitaxel and 24-Hour Infusion of High-Dose 5- Fluorouracil and Leucovorin in the Treatment of Recurrent or Metastatic Gastric Cancer
|
葉坤輝; 盧彥伸; 徐志宏; 林靜芳; 許駿; 郭頌鑫; 鄭安理; YEH, KUN-HUEI; LU, YEN-SHEN; HSU, CHIH-HUNG; LIN, JING-FANG; HSU, CHIUN; KUO, SUNG-HSIN; CHENG, ANN-LII |
| 國立臺灣大學 |
2005 |
Phosphorylation of Cytidine, Deoxycytidine, and Their Analog Monophosphates by Human Ump/Cmp Kinase Is Differentially Regulated by Atp and Magnesium
|
鄭永齊; 徐志宏; CHENG, YUNG-CHI; HSU, CHIH-HUNG |
| 國立臺灣大學 |
2004 |
濕地泥沙與水質模擬-以二重疏洪道濕地為例
|
徐志宏; Hsu, Chih-Hung |
| 國立臺灣大學 |
2004 |
Doxorubicin Activates Hepatitis B Virus (Hbv) Replication in Hbv- Harboring Hepatoblastoma Cells. A Possible Novel Mechanism of Hbv Reactivation in Hbv Carriers Receiving Systemic Chemotherapy
|
徐志宏; 許輝吉; 陳惠玲; 高明; 葉培彥; 陳培哲; 鄭安理; HSU, CHIH-HUNG; HSU, HEY-CHI; CHEN, HUI-LING; GAO, MING; YEH, PEI-YEN; CHEN, PEI-JER; CHENG, ANN-LII |
| 國立臺灣大學 |
2004 |
Weekly Gemcitabine Plus 24-Hour Infusion of High-Dose 5-Fluorouracil/ Leucovorin for Locally Advanced or Metastatic Carcinoma of the Biliary Tract.
|
許駿; 沈盈君; 楊志新; 葉坤輝; 盧彥伸; 徐志宏; 鄭安理; HSU, CHIUN; SHEN, YING-CHUN; YANG, CHIH-HSIN; YEH, KUN-HUEI; LU, YEN-SHEN; HSU, CHIH-HUNG; CHENG, ANN-LII |
| 國立臺灣大學 |
2004 |
Phase Ii Study of Combination Doxorubicin, Interferon-Alpha, and High- Dose Tamoxifen Treatment for Advanced Hepatocellular Carcinoma
|
盧彥伸; 許駿; 李啟誠; 郭頌鑫; 葉坤輝; 楊志新; 徐志宏; 吳貞瑤; 鄭安理; LU, YEN-SHEN; HSU, CHIUN; LI, CHI-CHENG; KUO, SUNG-HSIN; YEH, KUN-HUEI; YANG, CHIH-HSIN; HSU, CHIH-HUNG; WU, CHEN-YAO; CHENG, ANN-LII |
| 國立成功大學 |
2003-06 |
Steroid-free chemotherapy decreases risk of hepatitis B virus (HBV) reactivation in HBV-carriers with lymphoma
|
Cheng, Ann-Lii; Hsiung, Chao A.; Su, Ih-Jen; Chen, Pei-Jer; Chang, Ming-Chih; Tsao, Chao-Jung; Kao, Woei-Yao; Uen, Wu-Ching; Hsu, Chih-Hung; Tien, Hwei-Fan; Chao, Tsu-Yi; Chen, Li-Tzong; Jacqueline, Whang-Peng |
| 國立臺灣大學 |
2003 |
Steroid-Tree Chemotherapy Decreases Hepatitis B Virus (Hbv) Reactivation in Hbv-Carrier Lymphoma Patients
|
鄭安理; 熊昭; 蘇益仁; 陳培哲; 張明志; 曹朝榮; 高偉堯; 溫武慶; 徐志宏; 田蕙芬; 趙祖怡; 陳立宗; 彭汪嘉康; CHENG, ANN-LII; HSIUNG, CHAO A.; SU, IH-JEN; CHEN, PEI-JER; CHANG, MING-CHIH; TSAO, CHAO-JUNG; KAO, WOEI-YAU; UEN, WU-CHING; HSU, CHIH-HUNG; TIEN, HWEI-FANG; CHAO, TSU -YI; CHEN, LI-TZONG; WHANG-PENG, JACQUELINE |
| 國立成功大學 |
2002-06-03 |
不同外徑/壁厚比圓管在循環彎曲負載下黏塑性皺曲行為之研究
|
許志宏; Hsu, Chih-Hung |
| 國立臺灣大學 |
2002 |
P53 Overexpression Predicts Poor Chemosensitivity to High-Dose 5- Fluorouracil Plus Leucovorin Chemotherapy for Stage Iv Colorectal Cancers after Palliative Bowel Resection
|
梁金銅; 黃國晉; 鄭永銘; 許輝吉; 鄭安理; 徐志宏; 葉坤輝; 王世名; 張金堅; LIANG, JIN-TUNG; HUANG, KUO-CHIN; JENG, YUNG-MING; HSU, HEY-CHI; CHENG, ANN-LII; HSU, CHIH-HUNG; YEH, KUN-HUEI; WANG, SHIH-MING; CHANG, KING-JEN |
| 國立臺灣大學 |
2002 |
High-Frequency Microsatellite Instability Predicts Better Chemosensitivity to High-Dose 5-Fluorouracil Plus Leucovorin Chemotherapy for Stage Iv Sporadic Colorectal Cancer after Palliative Bowel Resection
|
梁金銅; 黃國晉; 賴鴻緒; 許輝吉; 徐志宏; LIANG, JIN-TUNG; HUANG, KUO-CHIN; LAI, HONG-SHIEE; HSU, HEY-CHI; HSU, CHIH-HUNG |
| 國立臺灣大學 |
2002 |
Induction of Epstein-Barr Rirus (Ebv) Reactivation in Raji Cells by Doxorubicin and Cisplatin
|
徐志宏; 鄭安理; HSU, CHIH-HUNG; CHENG, ANN-LII |
| 國立臺灣大學 |
2002 |
Prognostic Value of Multidrug Resistance 1 (Mdr 1), Glutathione-S- Transferase P (Gst P), and P53 in Advanced Nasopharyngeal Carcinoma (Npc) Treated with Systemic Chemotherapy
|
徐志宏; 陳志榮; 洪瑞隆; 林靜芳; 鄭安理; HSU, CHIH-HUNG; CHEN, CHI-LONG; HONG, RUEY-LONG; LIN, JING-FANG; CHENG, ANN-LII |
| 國立臺灣大學 |
2002 |
The Chemopreventive Compound Curcumin Is an Efficient Inhibitor of Epstein-Barr Virus Bzlf1 Transcription in Raji Dr-Luc Cells
|
徐志宏; 鄭安理; HSU, CHIH-HUNG; CHENG, ANN-LII |
| 國立臺灣大學 |
2002 |
A Phase Ii Study of Weekly Methotrexate, Cisplatin, and 24-Hour Infusion of High-Dose 5-Fluorouracil and Leucovorin (Mp-Hdfl) in Patients with Metastatic and Recurrent Esophageal Cancer-Improving Toxicity Profile by Infusional Schedule and Double Biochem
|
徐志宏; 鄭安理; 許駿; 楊志新; 盧彥伸; 卜慶芳; 葉坤輝; HSU, CHIH-HUNG; CHENG, ANN-LII; HSU, CHIUN; YANG, CHIH-HSIN; LU, YEN-SHEN; BU, CHING-FANG; YEH, KUN-HUEI |
| 國立臺灣大學 |
2002 |
Combination of 13-Cis Retinoic Acid and Interferon-Alpha in the Treatment of Recurrent or Refractory Peripheral T-Cell Lymphoma
|
黃敬倫; 蘇益仁; 田蕙芬; 唐季祿; 葉坤輝; 王秋華; 徐志宏; 鄭安理; HUANG, CHING-LUN; SU, IH-JEN; TIEN, HWEI-FANG; TANG, JIH-LUH; YEH, KUN-HUEI; WANG, CHIU-HWA; HSU, CHIH-HUNG; CHENG, ANN-LII |
| 國立臺灣大學 |
2001 |
Phase I Clinical Trial of Curcumin, a Chemopreventive Agent, in Patients with High-Risk or Pre-Malignant Lesions
|
鄭安理; 徐志宏; 林仁混; 徐茂銘; 沈宗憲; 何藴芳; 柯政郁; 林肇堂; 吳明賢; 紀秀華; CHENG, ANN-LII; HSU, CHIH-HUNG; LIN, JEN-KUN; HSU, MOW-MING; SHEEN, TZUNG-SHIAHN; HO, YUNN-FANG; KO, JENQ-YUH; LIN, JAW-TOWN; WU, MING-SHIANG; JEE, SHIOU-HWA |
| 國立臺灣大學 |
2001 |
A Pilot Study of Afl-T (Doxorubicin, 5-Fluorouracil, Leucovorin, and Tamoxifen) Combination Chemotherapy for Hormone-Refractory Prostate Cancer
|
林家齊; 徐志宏; 陳淳; 蔡崇璋; 鄭安理; 蒲永孝; LIN, CHIA-CHI; HSU, CHIH-HUNG; CHEN, JUN; TSAI, TSONG-CHANG; CHENG, ANN-LII; PU, YEONG-SHIAU |
| 國立臺灣大學 |
2001 |
Combination Chemotherapy of Cisplatin, Methotrexate, Vinblastine, and High-Dose Tamoxifen for Transitional Cell Carcinoma
|
徐志宏; 陳淳; 鄭安理; 蒲永孝; HSU, CHIH-HUNG; CHEN, JUN; CHENG, ANN-LII; PU, YEONG-SHIAU |
| 國立臺灣大學 |
2000 |
Curcumin-Containing Diet Inhibits Diethylnitrosamine-Induced Murine Hepatocarcinogenesis
|
莊雙恩; 郭明良; 徐志宏; 陳志榮; 林仁混; 賴基銘; 謝長堯; 鄭安理; CHUANG, SHUANG-EN; KUO, MIN-LIANG; HSU, CHIH-HUNG; CHEN, CHI-LONG; LIN, JEN-KUN; LAI, GI-MING; HSIEH, CHANG-YAO; CHENG, ANN-LII |
顯示項目 151-174 / 174 (共4頁)
<< < 1 2 3 4
每頁顯示[10|25|50]項目
|
